BIOTU
Biotech Acquisition Company Unit
BIOTU
BIOTU
Delisted
BIOTU was delisted on the 2nd of February, 2023.
0 hedge funds and large institutions have $0 invested in Biotech Acquisition Company Unit in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 5 closing their positions.
Holders
–
Holders Change
-5
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
1
Millennium Management
New York
|
$0 |
| 2 |
VF
2
Virtu Financial
New York
|
$0 |
| 3 |
3
Morgan Stanley
New York
|
$0 |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$0 |
| 5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| – | – | -40,000 | Closed |
|
|
VF
2
Virtu Financial
New York
| – | – | -12,968 | Closed |
|
|
3
Morgan Stanley
New York
| – | – | -551 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | – | -210 | Closed |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | – | -103 | Closed |
|
|
CFGS
6
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|